Roy Ovel, an industry leader with more than 35 years of experience in the pharmaceutical space, joins FindMeCure, a UK-based healthtech, to help the company expand to new segments of the clinical research market.
Known for his talent in developing and leading teams focused on high growth, Roy Ovel has facilitated the expansion of a diverse range of companies in the pharmaceutical space. In his most recent position as Chief Commercial Officer at Ergomed, Roy Ovel was responsible for global sales and business development activities across the company’s full-service offerings.
Since 2019, FindMeCure has been supporting the clinical research industry through its data intelligence platform TrialHub. TrialHub was built for clinical trial strategists at contract research organisations (CROs) and sponsor companies who need real-time feasibility and patient insights to predict study challenges.
Roy Ovel joins FindMeCure as Chief Commercial Officer at a critical moment. Having finalised a seed funding round, the company is ready to strengthen its position, expand its market share and advance the development of the in-house machine learning (ML) and natural language processing (NLP) technologies behind TrialHub’s success.
“I am extremely excited at the prospect of becoming part of the excellent team at FindMeCure. It is well-known that a significant factor in the success of clinical trials is robust data-driven feasibility. FindMeCure through their platform TrialHub, provides a feasibility assessment that is far above other industry tools. The provision of intelligence regarding the country-level patient pathways, standard of care and drug reimbursement offers the clinical researcher invaluable insight into the most efficient and cost-effective recruitment strategy. This will allow the industry to potentially increase the speed to market, thereby getting much-needed medicines to patients sooner”, said Roy Ovel.
“In the last three years, TrialHub and the team behind it proved that clinical trials can be planned more efficiently by supporting more than 3,000 trials to date. Our close collaboration with forward-thinking CROs and sponsors allowed us to validate that successful patient recruitment requires much more than what traditional site feasibility solutions offer today. TrialHub provides the most accurate real-time analysis of the clinical trial landscape, which directly contributes to the CROs’ business growth. I am looking forward to working with an expert like Roy Ovel to make sure that more companies and clinical trials can benefit from our data,” said Maya Zlatanova, CEO of FindMeCure.
In his new position as the Chief Commercial Officer of FindMeCure, Roy Ovel will build upon the company’s commercial success, ultimately helping FindMeCure achieve what it says on the tin: bring research closer to patients.